These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1420824)

  • 1. Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolism.
    Tebbe U; Seifried E; Carlsson J; Tanswell P
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):475-80. PubMed ID: 1420824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
    Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
    Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
    Mühl D
    Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction.
    Stangl K; Laule M; Tenckhoff B; Stangl V; Gliech V; Dübel P; Grohmann A; Melzer C; Langel J; Wernecke KD; Baumann G; Ziemer S
    Am J Cardiol; 1998 Apr; 81(7):841-7. PubMed ID: 9555772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
    Goldhaber SZ; Agnelli G; Levine MN
    Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
    Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
    Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
    Vaughan DE; Goldhaber SZ; Kim J; Loscalzo J
    Circulation; 1987 Jun; 75(6):1200-3. PubMed ID: 3105914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up.
    Meneveau N; Schiele F; Metz D; Valette B; Attali P; Vuillemenot A; Grollier G; Elaerts J; Mossard JM; Viel JF; Bassand JP
    J Am Coll Cardiol; 1998 Apr; 31(5):1057-63. PubMed ID: 9562007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful alteplase bolus administration for a presumed massive pulmonary embolism during cardiopulmonary resuscitation.
    Prom R; Dull R; Delk B
    Ann Pharmacother; 2013 Dec; 47(12):1730-5. PubMed ID: 24259620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
    Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
    J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue plasminogen activator and acute pulmonary embolism.
    Goldhaber SZ; Kessler CM; Heit J; Markis JE; Sharma GV; Dawley DL; Meyerovitz MF; Vaughan DE; Parker JA; Come PC
    J Cell Biochem; 1988 Dec; 38(4):303-12. PubMed ID: 3149283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism.
    Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H
    Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 16. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.
    Meyer G; Sors H; Charbonnier B; Kasper W; Bassand JP; Kerr IH; Lesaffre E; Vanhove P; Verstraete M
    J Am Coll Cardiol; 1992 Feb; 19(2):239-45. PubMed ID: 1732347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive pulmonary embolism and cardiac arrest; thrombolytic therapy in a patient with recent intracranial surgery and glioblastoma multiforme.
    Bayram B; Oray NÇ; Korkmaz E; Erdost HA; Gokmen N
    Am J Emerg Med; 2014 Nov; 32(11):1441.e1-3. PubMed ID: 25009081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
    Levine MN; Weitz J; Turpie AG; Andrew M; Cruickshank M; Hirsh J
    Chest; 1990 Apr; 97(4 Suppl):168S-171S. PubMed ID: 2108854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.